US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

527.78

-19.8900-3.63%

Post-market: 529.401.62+0.31%19:55 EDT

Volume:1.50M

Turnover:803.69M

Market Cap:57.00B

PE:13.39

High:552.84

Open:549.00

Low:527.13

Close:547.67

Loading ...

Overview Company News Filings

Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Regeneron Pharma Is Maintained at Hold by Canaccord Genuity

Regeneron Says Application for Expanded Use of Eylea Accepted for FDA Priority Review

MT Newswires Live

Regeneron Gets FDA Priority Review for Expanded Eylea HD Use

Regeneron Pharma Is Maintained at Underperform by B of A Securities

BRIEF-Eylea Hd® (Aflibercept) Injection 8 Mg Sbla Accepted For FDA Priority Review

Regeneron Pharmaceuticals Inc - FDA Target Action Date for Eylea Hd Sbla Is August 19, 2025

THOMSON REUTERS

Eylea Hd® (Aflibercept) Injection 8 Mg Sbla Accepted for FDA Priority Review for Both the Treatment of Macular Edema Following Retinal Vein Occlusion (Rvo) and for Monthly Dosing in Approved Indications

THOMSON REUTERS

Regeneron Pharmaceuticals Inc : Bofa Global Research Cuts Price Objective to $547 From $575

THOMSON REUTERS

Regeneron’s odronextamab granted FDA orphan designation

Regeneron Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers

Biocon Says Biocon Biologics Secures U.S. Market Entry For Yesafili Biosimilar

This Cholesterol Gene Medicine Could Work in 1 Shot. It Could Also Bring This Biotech Stock Back to Life. -- Barrons.com

Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)

US FDA Animal Testing De-Emphasis May Boost Biotech Innovation, RBC Says

MT Newswires Live

Regeneron Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

Guggenheim Adjusts Price Target on Regeneron Pharmaceuticals to $940 From $950, Maintains Buy Rating

MT Newswires Live

Regeneron price target lowered to $940 from $950 at Guggenheim

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/REGN/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"REGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REGN\",,,,,undefined,":{"symbol":"REGN","market":"US","secType":"STK","nameCN":"Regeneron Pharmaceuticals","latestPrice":527.78,"timestamp":1746820800000,"preClose":547.67,"halted":0,"volume":1499172,"hourTrading":{"tag":"盘后","latestPrice":529.4,"preClose":527.78,"latestTime":"19:55 EDT","volume":92932,"amount":49046594.1781,"timestamp":1746834933502},"delay":0,"floatShares":105000000,"shares":108000000,"eps":39.427654,"marketStatus":"Market Closed","change":-19.89,"latestTime":"05-09 16:00:00 EDT","open":549,"high":552.84,"low":527.13,"amount":803694715.4928,"amplitude":0.046944,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":39.427654,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":547.67,"dividendRate":0.001667,"preHourTrading":{"tag":"盘前","latestPrice":545.02,"preClose":547.67,"latestTime":"09:29 EDT","volume":8541,"amount":4677532.4583,"timestamp":1746797352955},"postHourTrading":{"tag":"盘后","latestPrice":529.4,"preClose":527.78,"latestTime":"19:55 EDT","volume":92932,"amount":49046594.1781,"timestamp":1746834933502},"volumeRatio":0.926316058709841,"impliedVol":0.512,"impliedVolPercentile":0.956},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REGN\",,,,,undefined,":{"symbol":"REGN","floatShares":105000000,"roa":"6.91%","roe":"15.96%","lyrEps":40.895273,"volumeRatio":0.926316058709841,"shares":108000000,"dividePrice":0.88,"high":552.84,"amplitude":0.046944,"preClose":547.67,"low":527.13,"week52Low":520.5,"pbRate":"1.94","psRate":"4.05","week52High":1211.2,"institutionHeld":0.8855,"latestPrice":527.78,"eps":39.427654,"divideRate":0.001667,"volume":1499172,"delay":0,"ttmEps":39.427654,"open":549,"prevYearClose":712.33,"prevWeekClose":605.61,"prevMonthClose":598.76,"prevQuarterClose":634.23,"fiveDayClose":605.61,"twentyDayClose":546.39,"sixtyDayClose":663.86},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"REGN\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528096229","title":"Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2528096229","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528096229?lang=en_us&edition=fundamental","pubTime":"2025-04-18 23:15","pubTimestamp":1744989300,"startTime":"0","endTime":"0","summary":"Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo. In the U.S., there are more than 300,000 adults and adolescents aged 12 years and older living with CSU who remain symptomatic despite antihistamine treatment. CSU is the seventh disease with underlying type 2 inflammation in which Dupixent is approved. The U.S. approval is based on data from two Phase 3 clinical trials, Study A  and Study C , which included biologic-nave patients aged 12 years and older who were symptomatic despite the use of antihistamines and assessed Dupixent as an add-on therapy to standard-of-care antihistamines, compared to antihistamines alone. Both trials met their primary and key secondary endpoints with Dupixent demonstrating reductions in itch severity and urticaria activity  compared to placebo at 24 weeks. Dupixent also increased the likelihood of well-controlled disease or complete response compared to placebo at 24 weeks. Study B  provided a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dupixent-dupilumab-approved-u-first-151500962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2023250504.SGD","LU0889565916.HKD","SNY","LU0058720904.USD","BK4588","BK4096","LU1917777945.USD","LU1974910355.USD","PN","LU0823416689.USD","LU0289739699.SGD","IE00BFXG1179.USD","LU2362541273.HKD","LU2237438978.USD","LU0109394709.USD","LU0114720955.EUR","REGN","LU2089984988.USD","BK4585","UAE","LU2362541513.USD","LU2106854487.HKD","BK4007","LU2362540622.SGD","LU2468319806.SGD","LU0320765992.SGD","BK4139","LU0053666078.USD","LU0882574055.USD"],"gpt_icon":0},{"id":"2528664776","title":"Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2528664776","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528664776?lang=en_us&edition=fundamental","pubTime":"2025-04-18 04:45","pubTimestamp":1744922700,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  advanced 2.53% to $563.16 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  rising 0.13% to 5,282.70 and the Dow Jones Industrial Average  falling 1.33% to 39,142.23.The stock's rise snapped a two-day losing streak.Regeneron Pharmaceuticals Inc. closed 53.50% short of its 52-week high of $1,211.20, which the company achieved on August 27th.The stock outperformed some of its competitors Thursday, as Amgen Inc.  fell 1.89% to $277.29, Moderna Inc.  fell 1.89% to $24.72, and Gilead Sciences Inc.  fell 0.32% to $104.54.Trading volume  remained 189,233 below its 50-day average volume of 1.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 17, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jon","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"gpt_icon":0},{"id":"2528714957","title":"Regeneron Pharma Is Maintained at Hold by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2528714957","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528714957?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:43","pubTimestamp":1744893780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/REGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 17, 2025 08:43 ET (12:43 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","BK4139","LU2362541273.HKD","LU2089984988.USD","LU2362540622.SGD","LU0058720904.USD","LU2023250504.SGD","LU1974910355.USD","LU0109394709.USD","REGN","LU1917777945.USD","LU0889565916.HKD","LU0114720955.EUR","LU2237438978.USD","LU0289739699.SGD","LU2362541513.USD","LU0823416689.USD","BK4585","LU0320765992.SGD","LU2106854487.HKD","BK4588","LU0882574055.USD","LU2468319806.SGD"],"gpt_icon":0},{"id":"2528671516","title":"Regeneron Says Application for Expanded Use of Eylea Accepted for FDA Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2528671516","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528671516?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:47","pubTimestamp":1744890439,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals  said Thursday that its supplemental biologics license application for Eylea HD 8 mg injection has been accepted for priority review by the US Food and Drug Administration, with a decision expected by Aug. 19.The company said it is seeking approval for Eylea, or aflibercept, to treat macular edema following retinal vein occlusion and to expand Eylea HD's dosing schedule to include every 4-week dosing across approved indications.The submission is backed by data from a phase 3 trial, which showed that patients who received Eylea HD every 8 weeks achieved similar vision outcomes compared with those receiving the drug every 4 weeks, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0868494708.USD","LU2362540622.SGD","LU0868494617.USD","LU1929549753.HKD","LU2089984988.USD","LU0823416689.USD","LU2756315664.SGD","LU1162221912.USD","LU1674673691.USD","BK4139","LU1035775433.USD","BK4534","REGN","LU1674673428.USD","LU0820561818.USD","LU0109394709.USD","LU0079474960.USD","LU0289739699.SGD","LU2362541513.USD","LU1917777945.USD","IE00BZ1G4Q59.USD","BK4504","HD","LU0942090050.USD","LU1093756168.USD","LU2362541273.HKD","LU0823411888.USD","IE00B1XK9C88.USD","BK4566","LU0053666078.USD","LU0889565916.HKD","LU0882574055.USD","BK4588","BK4585","LU0354030438.USD","LU0820561909.HKD","BK4581","LU0320765992.SGD","LU1914381329.SGD","LU2106854487.HKD","LU0689472784.USD","LU0114720955.EUR","LU0823434583.USD","LU1974910355.USD","LU2237438978.USD","LU1093756325.SGD","LU0320765646.SGD","BK4083","LU2023250504.SGD","LU1551013342.USD"],"gpt_icon":0},{"id":"2528715154","title":"Regeneron Gets FDA Priority Review for Expanded Eylea HD Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2528715154","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528715154?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:46","pubTimestamp":1744890360,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals has won U.S. Food and Drug Administration priority review for its application seeking expanded approval of its Eylea HD eye drug.Regeneron on Thursday said the application covers Eylea HD for the treatment of macular edema following retinal vein occlusion and for broadening the dosing schedule to include monthly dosing across approved indications.The FDA grants priority review to medicines that have the potential to provide significant improvements in the treatment of a serious disease, and the designation shortens the review period.Regeneron said the FDA has set a target action date of Aug. 19 for the application after the Tarrytown, N.Y., biotechnology company used a priority-review voucher.The company said an FDA green light would make Eylea HD the first and only treatment for retinal vein occlusion indicated for up to every-eight-week dosing after an initial monthly dosing period, halving the number of injections that are indicated for all other anti-VEGF ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1974910355.USD","LU1917777945.USD","BK4585","LU2362541273.HKD","LU0109394709.USD","LU2089984988.USD","LU2362541513.USD","LU2468319806.SGD","BK4139","BK4588","HD","REGN","LU0053666078.USD","LU0320765992.SGD","LU2237438978.USD","LU0882574055.USD","LU0114720955.EUR","LU0823416689.USD","LU0289739699.SGD","LU2023250504.SGD","LU2106854487.HKD","LU2362540622.SGD","LU0889565916.HKD","LU0058720904.USD"],"gpt_icon":0},{"id":"2528718929","title":"Regeneron Pharma Is Maintained at Underperform by B of A Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2528718929","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528718929?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:20","pubTimestamp":1744888800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/REGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 17, 2025 07:20 ET (11:20 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"gpt_icon":0},{"id":"2528790149","title":"BRIEF-Eylea Hd® (Aflibercept) Injection 8 Mg Sbla Accepted For FDA Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2528790149","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528790149?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:07","pubTimestamp":1744888023,"startTime":"0","endTime":"0","summary":"BRIEF-Eylea Hd (Aflibercept) Injection 8 Mg Sbla Accepted For FDA Priority Review April 17 (Reuters) - Regeneron Pharmaceuticals Inc REGN.O:EYLEA HD (AFLIBERCEPT) INJECTION 8 MG SBLA ACCEPTED FOR FDA ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA9QTTVX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1974910355.USD","LU1917777945.USD","BK4585","LU2362541273.HKD","LU0109394709.USD","LU2089984988.USD","LU2362541513.USD","LU2468319806.SGD","BK4139","BK4588","REGN","LU0053666078.USD","LU0320765992.SGD","LU2237438978.USD","LU0882574055.USD","LU0114720955.EUR","LU0823416689.USD","LU0289739699.SGD","LU2023250504.SGD","LU2106854487.HKD","LU2362540622.SGD","LU0889565916.HKD","LU0058720904.USD"],"gpt_icon":0},{"id":"2528797028","title":"Regeneron Pharmaceuticals Inc - FDA Target Action Date for Eylea Hd Sbla Is August 19, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2528797028","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528797028?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:00","pubTimestamp":1744887608,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA9QTTVX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["REGN","LU0114720955.EUR","BK4585","BK4139","LU0058720904.USD","LU1917777945.USD","LU0109394709.USD","LU0882574055.USD","LU0823416689.USD","LU2362541513.USD","LU2468319806.SGD","LU0889565916.HKD","LU2089984988.USD","LU2023250504.SGD","LU0289739699.SGD","LU1974910355.USD","LU2237438978.USD","LU0320765992.SGD","LU2106854487.HKD","LU2362540622.SGD","LU0053666078.USD","LU2362541273.HKD","BK4588"],"gpt_icon":0},{"id":"2528797005","title":"Eylea Hd® (Aflibercept) Injection 8 Mg Sbla Accepted for FDA Priority Review for Both the Treatment of Macular Edema Following Retinal Vein Occlusion (Rvo) and for Monthly Dosing in Approved Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2528797005","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528797005?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:00","pubTimestamp":1744887608,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA9QTTVX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["REGN","LU2362541273.HKD","LU2362540622.SGD","LU0882574055.USD","BK4585","LU0058720904.USD","LU2237438978.USD","LU1917777945.USD","LU0109394709.USD","LU0320765992.SGD","LU2362541513.USD","LU0114720955.EUR","BK4139","LU2106854487.HKD","LU2089984988.USD","LU2468319806.SGD","LU0289739699.SGD","LU2023250504.SGD","LU0889565916.HKD","BK4588","LU0823416689.USD","LU1974910355.USD","LU0053666078.USD"],"gpt_icon":0},{"id":"2528779182","title":"Regeneron Pharmaceuticals Inc : Bofa Global Research Cuts Price Objective to $547 From $575","url":"https://stock-news.laohu8.com/highlight/detail?id=2528779182","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528779182?lang=en_us&edition=fundamental","pubTime":"2025-04-17 18:12","pubTimestamp":1744884736,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QV1TM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","LU1974910355.USD","LU0053666078.USD","LU2023250504.SGD","REGN","LU2468319806.SGD","LU0823416689.USD","LU0882574055.USD","LU2362540622.SGD","LU0320765992.SGD","BK4139","BK4585","LU1917777945.USD","LU2106854487.HKD","LU0058720904.USD","LU2089984988.USD","LU0889565916.HKD","LU0289739699.SGD","LU2362541513.USD","LU2237438978.USD","LU0109394709.USD","LU2362541273.HKD","LU0114720955.EUR"],"gpt_icon":0},{"id":"2528201143","title":"Regeneron’s odronextamab granted FDA orphan designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2528201143","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528201143?lang=en_us&edition=fundamental","pubTime":"2025-04-17 06:00","pubTimestamp":1744840823,"startTime":"0","endTime":"0","summary":"Regeneron’s (REGN) odronextamab was granted FDA orphan designation as a treatment of splenic marginal zone lymphoma, according to a post to the age...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regenerons-odronextamab-granted-fda-orphan-designation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regenerons-odronextamab-granted-fda-orphan-designation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823416689.USD","LU0058720904.USD","LU0889565916.HKD","LU2237438978.USD","LU2468319806.SGD","BK4585","LU0320765992.SGD","BK4588","LU2362541273.HKD","LU0053666078.USD","LU2106854487.HKD","LU2362540622.SGD","BK4139","REGN","LU2089984988.USD","LU0882574055.USD","LU1974910355.USD","LU2362541513.USD","LU2023250504.SGD","LU0109394709.USD","LU1917777945.USD","LU0289739699.SGD","LU0114720955.EUR"],"gpt_icon":0},{"id":"2527047868","title":"Regeneron Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2527047868","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527047868?lang=en_us&edition=fundamental","pubTime":"2025-04-16 04:44","pubTimestamp":1744749840,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  slipped 2.30% to $557.91 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.17% to 5,396.63 and Dow Jones Industrial Average  falling 0.38% to 40,368.96.The stock's fall snapped a two-day winning streak.Regeneron Pharmaceuticals Inc. closed 53.94% short of its 52-week high of $1,211.20, which the company reached on August 27th.The stock underperformed when compared to some of its competitors Tuesday, as Amgen Inc.  rose 0.47% to $295.30, Moderna Inc.  fell 2.09% to $26.24, and Gilead Sciences Inc.  fell 0.77% to $105.68.Trading volume  remained 200,954 below its 50-day average volume of 1.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 15, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"gpt_icon":0},{"id":"2527413411","title":"Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2527413411","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527413411?lang=en_us&edition=fundamental","pubTime":"2025-04-15 17:02","pubTimestamp":1744707776,"startTime":"0","endTime":"0","summary":"Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Exact Sciences  and its peers.Over the next few years, immuno-oncology companies, which harness the immune system to fight illnesses such as cancer, faces strong tailwinds from advancements in precision medicine  and growing demand for treatments targeting rare diseases. However, headwinds such as rising scrutiny over drug pricing, regulatory unknowns, and competition from larger, more resourced pharmaceutical companies could weigh on growth.The 4 immuno-oncology stocks we track reported a strong Q4. As a group, revenues beat analysts’ consensus estimates by 3.5%.Amidst this news, share prices of the companies have had a rough stretch. On average, they are down 12.6% since the latest earnings results.With a mission to detect cancer earlier when it's more treatable, Exact Sciences  develops and markets cancer screening and diagnostic tests, including its flagsh","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/immuno-oncology-stocks-q4-review-090256516.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2065170008.USD","BK4139","LU2095319765.USD","NTRA","PSQ","LU0109394709.USD","REGN","IE00B3QW5Z07.USD","LU2324357040.USD","BK4532","LU0053666078.USD","BK4585","USAW.SI","QID","BK4112","INCY","LU0882574055.USD","LU1988902786.USD","LU2210149790.SGD","LU2468319806.SGD","LU0823416689.USD","LU2237438978.USD","TQQQ","LU1974910355.USD","NDAQ","TSYW.SI","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2065171311.SGD","LU2023250504.SGD","LU2210150020.SGD","LU0289739699.SGD","LU1064131342.USD","LU1917777945.USD","NVIW.SI","LU0320765992.SGD","LU2106854487.HKD","SQQQ","MNQmain","IE00B64PRP62.GBP",".IXIC","LU2089984988.USD","QLD","NQmain","LU2362541273.HKD","LU2362541513.USD","EXAS","USJW.SI","LU2264538146.SGD"],"gpt_icon":1},{"id":"2527369456","title":"Biocon Says Biocon Biologics Secures U.S. Market Entry For Yesafili Biosimilar","url":"https://stock-news.laohu8.com/highlight/detail?id=2527369456","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527369456?lang=en_us&edition=fundamental","pubTime":"2025-04-15 15:29","pubTimestamp":1744702158,"startTime":"0","endTime":"0","summary":"April 15 (Reuters) - Biocon Ltd ::*BIOCON LTD - BIOCON BIOLOGICS SECURES U.S. MARKET ENTRY FOR YESAFILI BIOSIMILAR*BIOCON LTD - YESAFILI TO LAUNCH IN U.S. IN SECOND HALF OF 2026 OR EARLIER*BIOCON - BI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nRSD74z14h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","LU0882574055.USD","LU0289739699.SGD","LU2362540622.SGD","LU0823416689.USD","LU2362541273.HKD","LU2237438978.USD","LU0109394709.USD","LU0114720955.EUR","LU2468319806.SGD","LU2362541513.USD","LU1974910355.USD","REGN","LU0320765992.SGD","BK4588","LU2089984988.USD","LU0058720904.USD","LU2023250504.SGD","BK4585","BK4139","LU1917777945.USD","LU0889565916.HKD","LU2106854487.HKD"],"gpt_icon":0},{"id":"2527116967","title":"This Cholesterol Gene Medicine Could Work in 1 Shot. It Could Also Bring This Biotech Stock Back to Life. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2527116967","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527116967?lang=en_us&edition=fundamental","pubTime":"2025-04-15 01:27","pubTimestamp":1744651620,"startTime":"0","endTime":"0","summary":"A single infusion of a Verve Therapeutics gene-editing treatment cut dangerously high levels of cholesterol in a group of patients by more than half. The company reported Monday that cholesterol levels fell by 59% in the first month, with no significant side effects, for patients getting the high dose.There were 14 patients in Verve's Phase 1 trail, which it called Heart-2. Higher doses of its genetic medicine led to deeper cuts in the harmful form of cholesterol known as LDL-C.\"These initial Heart-2 data are promising with respect to both safety and efficacy and suggest the potential for a new era of cardiovascular disease treatment where a single dose might lead to lifelong control of LDL-C,\" said Harvard Medical School professor Eugene Braunwald, in Verve's press release.As with many firms developing therapies, Verve is testing its PCSK9 editor on the sickest patients fi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417517546.SGD","LU1868836757.USD","LU0094547139.USD","SG9999014880.SGD","VERV","LU2089984988.USD","LU2361045086.USD","LU0203202063.USD","LU0238689110.USD","LU0385154629.USD","LU1983299246.USD","IE00B2B36J28.USD","SG9999015978.USD","LU1814569148.SGD","IE0002141913.USD","LU0820561818.USD","LU1023059063.AUD","REGN","LU2357305700.SGD","LU1988902786.USD","LU1623119135.USD","LU1366192091.USD","LU2264538146.SGD","LU2112291526.USD","LU0006306889.USD","BK4578","LU0320765992.SGD","LU1917777945.USD","AMGN","IE00B1BXHZ80.USD","LU2237443622.USD","LU1064131342.USD","LU1551013342.USD","SG9999015945.SGD","SG9999001176.SGD","LU1069344957.HKD","LU1804176565.USD","LU0354030511.USD","BK4532","LU0640476718.USD","LU2237443895.HKD","NVS","SG9999014906.USD","BK4539","IE00BK4W5L77.USD","IE0009355771.USD","LU2106854487.HKD","LU1291159041.SGD","SGXZ81514606.USD"],"gpt_icon":1},{"id":"2527187641","title":"Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2527187641","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527187641?lang=en_us&edition=fundamental","pubTime":"2025-04-14 17:01","pubTimestamp":1744621267,"startTime":"0","endTime":"0","summary":"Looking back on immuno-oncology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Regeneron  and its peers.Over the next few years, immuno-oncology companies, which harness the immune system to fight illnesses such as cancer, faces strong tailwinds from advancements in precision medicine  and growing demand for treatments targeting rare diseases. However, headwinds such as rising scrutiny over drug pricing, regulatory unknowns, and competition from larger, more resourced pharmaceutical companies could weigh on growth.The 4 immuno-oncology stocks we track reported a strong Q4. As a group, revenues beat analysts’ consensus estimates by 3.5%.Amidst this news, share prices of the companies have had a rough stretch. On average, they are down 15% since the latest earnings results.Natera delivered the biggest analyst estimates beat, fastest revenue growth, and highest full-year guidance raise among its peers. Although it had a fine quarter compared its peers,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/reflecting-immuno-oncology-stocks-q4-090107276.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EXAS","REGN","NTRA",".IXIC","NDAQ"],"gpt_icon":0},{"id":"2526660207","title":"US FDA Animal Testing De-Emphasis May Boost Biotech Innovation, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2526660207","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526660207?lang=en_us&edition=fundamental","pubTime":"2025-04-11 22:03","pubTimestamp":1744380195,"startTime":"0","endTime":"0","summary":"The US Food and Drug Administration's plan to decrease preclinical animal study requirements for investigational new drug applications could be positive for the biotech sector as it may further encourage innovation, RBC Capital Markets said in a note emailed Friday.Antibody innovators like Regeneron Pharmaceuticals , Amgen , Viridian Therapeutics , BeiGene , Xencor , and Ultragenyx Pharmaceutical  stand to benefit the most from the new approach, the note said.RBC analysts said the move toward \"increased regulatory flexibility\" represents a \"net positive, especially given recent concerns about potential FDA dysfunction and potentially greater stringency.\"However, this \"will likely start small, and we are likely still years away from these specific approaches being proven and implemented on a broad enough scale to significantly affect the group,\" the note said.The regulatory move may be especially beneficial for \"early-stage development/new company creation, and reducing development time","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2362541513.USD","LU2023250504.SGD","XNCR","BK4581","ONC","LU1983299246.USD","IE00BJJMRZ35.SGD","LU0114720955.EUR","LU0109394709.USD","LU0122379950.USD","LU2242652126.USD","LU1974910355.USD","LU2089984988.USD","LU2362540622.SGD","LU2468319806.SGD","LU0889565916.HKD","LU2112291526.USD","LU2362541273.HKD","SG9999001440.SGD","BK4534","VRDN","IE00B2B36J28.USD","BK4588","LU0053666078.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU0289739699.SGD","LU1917777945.USD","AMGN","LU1023059063.AUD","BK4585","LU0320765992.SGD","LU1061106388.HKD","IE00BJT1NW94.SGD","LU2106854487.HKD","BK4139","LU1571399168.USD","IE0002141913.USD","IE0009355771.USD","LU2242646821.SGD","LU2237438978.USD","REGN","LU0868494617.USD","BK4599","BK4566","LU1057294990.SGD","BK4533","LU0882574055.USD","IE00B4R5TH58.HKD","RARE"],"gpt_icon":0},{"id":"2526443335","title":"Regeneron Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2526443335","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526443335?lang=en_us&edition=fundamental","pubTime":"2025-04-11 04:45","pubTimestamp":1744317900,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  shed 5.26% to $546.39 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 3.46% to 5,268.05 and Dow Jones Industrial Average  falling 2.50% to 39,593.66.Regeneron Pharmaceuticals Inc. closed 54.89% short of its 52-week high of $1,211.20, which the company reached on August 27th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Amgen Inc.  fell 3.33% to $281.41, Moderna Inc.  fell 8.14% to $24.50, and Gilead Sciences Inc.  fell 3.66% to $101.40.Trading volume  eclipsed its 50-day average volume of 1.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 10, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Jo","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"gpt_icon":0},{"id":"2526514232","title":"Guggenheim Adjusts Price Target on Regeneron Pharmaceuticals to $940 From $950, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2526514232","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526514232?lang=en_us&edition=fundamental","pubTime":"2025-04-11 01:33","pubTimestamp":1744306429,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals (REGN) has an average rating of overweight and mean price target of $923.27, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic resea","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["REGN"],"gpt_icon":0},{"id":"2526568298","title":"Regeneron price target lowered to $940 from $950 at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2526568298","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526568298?lang=en_us&edition=fundamental","pubTime":"2025-04-10 19:50","pubTimestamp":1744285811,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Yatin Suneja lowered the firm’s price target on Regeneron (REGN) to $940 from $950 and keeps a Buy rating on the shares. The fir...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regeneron-price-target-lowered-to-940-from-950-at-guggenheim?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regeneron-price-target-lowered-to-940-from-950-at-guggenheim?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0053666078.USD","LU0882574055.USD","LU0289739699.SGD","LU2362540622.SGD","LU0823416689.USD","LU2362541273.HKD","LU2237438978.USD","LU0109394709.USD","LU0114720955.EUR","LU2468319806.SGD","LU2362541513.USD","LU1974910355.USD","REGN","LU0320765992.SGD","BK4588","LU2089984988.USD","LU0058720904.USD","LU2023250504.SGD","BK4585","BK4139","LU1917777945.USD","LU0889565916.HKD","LU2106854487.HKD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/REGN\",params:#limit:5,,,undefined,":[{"date":"2025-05-20","symbol":"REGN","amount":0.88,"announcedDate":"2025-04-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-20","defaultRemindTime":1747747800000,"name":"再生元制药公司","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-06","payableDate":"2025-05-20","currency":"USD","dateTimestamp":1747713600000,"payDate":"2025-06-06"},{"market":"US","date":"2025-04-29","symbol":"REGN","fiscalQuarterEnding":"2025/03","expectedEps":6.61,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1745899200000,"reportTimeType":"pre","actualEps":6.43},{"date":"2025-02-20","symbol":"REGN","amount":0.88,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-20","defaultRemindTime":1740061800000,"name":"再生元制药公司","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-20","payableDate":"2025-02-20","currency":"USD","dateTimestamp":1740027600000,"payDate":"2025-03-20"},{"market":"US","date":"2025-02-04","symbol":"REGN","fiscalQuarterEnding":"2024/12","expectedEps":9.62,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738645200000,"reportTimeType":"pre","actualEps":9.9},{"market":"US","date":"2024-10-31","symbol":"REGN","fiscalQuarterEnding":"2024/09","expectedEps":10.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"pre","actualEps":11.73}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"REGN\",market:\"US\",,,undefined,":[{"executeDate":"2025-02-20","recordDate":"2025-02-20","paymentDate":"2025-03-20","value":0.88,"currency":"USD"},{"executeDate":"2025-05-20","recordDate":"2025-05-20","paymentDate":"2025-06-06","value":0.88,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"REGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.4643,"hold":0.1786,"sell":0.0714,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4643,"analysts":28,"updateTime":1745985600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/REGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"REGN","date":"2025-05-09","current":12.861961,"percent":0.226016,"low":7.447139,"twenty":11.205526,"median":16.904119,"eighty":24.034457,"high":30.763504,"avg":17.458588,"sd":6.158396,"marketCap":57869822741},"quantilePoints":[{"date":"2020-05-15","current":28.176995,"twenty":19.849021,"median":53.421195,"eighty":115.221021,"marketCap":64223824676},{"date":"2020-05-22","current":27.844277,"twenty":19.849021,"median":51.799637,"eighty":114.184286,"marketCap":63465459705},{"date":"2020-05-29","current":27.303609,"twenty":19.849021,"median":51.530268,"eighty":113.633942,"marketCap":62233116768},{"date":"2020-06-05","current":26.599198,"twenty":19.849021,"median":51.349129,"eighty":112.594309,"marketCap":60627552930},{"date":"2020-06-12","current":26.215582,"twenty":19.849021,"median":51.102486,"eighty":112.289501,"marketCap":59753175659},{"date":"2020-06-19","current":28.689708,"twenty":19.849021,"median":50.420041,"eighty":111.71033,"marketCap":65392452064},{"date":"2020-06-26","current":27.239005,"twenty":19.849021,"median":49.850558,"eighty":110.92935,"marketCap":62085863918},{"date":"2020-07-02","current":27.733117,"twenty":19.849021,"median":40.392331,"eighty":110.784746,"marketCap":63212094340},{"date":"2020-07-10","current":27.662275,"twenty":19.849021,"median":31.979399,"eighty":110.206964,"marketCap":63050623973},{"date":"2020-07-17","current":28.695946,"twenty":19.849021,"median":31.36985,"eighty":108.726161,"marketCap":65406669581},{"date":"2020-07-24","current":27.131182,"twenty":19.849021,"median":31.004812,"eighty":106.696094,"marketCap":61840103988},{"date":"2020-07-31","current":28.161734,"twenty":19.849021,"median":30.808341,"eighty":104.408478,"marketCap":64189040838},{"date":"2020-08-07","current":21.875339,"twenty":19.849021,"median":30.656632,"eighty":101.923911,"marketCap":65265075387},{"date":"2020-08-14","current":21.60587,"twenty":19.849021,"median":30.354205,"eighty":101.37008,"marketCap":64461113542},{"date":"2020-08-21","current":21.356152,"twenty":19.849021,"median":30.042238,"eighty":99.974583,"marketCap":63716080837},{"date":"2020-08-28","current":21.254572,"twenty":19.849021,"median":29.867177,"eighty":98.620251,"marketCap":63413016686},{"date":"2020-09-04","current":20.469796,"twenty":19.849021,"median":29.681793,"eighty":97.739726,"marketCap":61071635658},{"date":"2020-09-11","current":19.2138,"twenty":19.673575,"median":29.474412,"eighty":97.336675,"marketCap":57324373708},{"date":"2020-09-18","current":19.583792,"twenty":19.656234,"median":29.203553,"eighty":96.645594,"marketCap":58428242785},{"date":"2020-09-25","current":20.247589,"twenty":19.637789,"median":29.093505,"eighty":95.995591,"marketCap":60408682828},{"date":"2020-10-02","current":19.920981,"twenty":19.637789,"median":28.953278,"eighty":94.856997,"marketCap":59434247398},{"date":"2020-10-09","current":21.235526,"twenty":19.637789,"median":28.860353,"eighty":93.407176,"marketCap":63356192158},{"date":"2020-10-16","current":21.153345,"twenty":19.637789,"median":28.756642,"eighty":89.782622,"marketCap":63111004841},{"date":"2020-10-23","current":20.450397,"twenty":19.637789,"median":28.691316,"eighty":88.348748,"marketCap":61013758824},{"date":"2020-10-30","current":19.171828,"twenty":19.596771,"median":28.536662,"eighty":84.18776,"marketCap":57199149284},{"date":"2020-11-06","current":19.330759,"twenty":19.563112,"median":28.419067,"eighty":80.669454,"marketCap":61007874618},{"date":"2020-11-13","current":18.942826,"twenty":19.391778,"median":28.342989,"eighty":76.671574,"marketCap":59783558673},{"date":"2020-11-20","current":17.347954,"twenty":19.273386,"median":28.194062,"eighty":74.98798,"marketCap":54750142517},{"date":"2020-11-27","current":17.191109,"twenty":19.172764,"median":28.166858,"eighty":74.433116,"marketCap":54255138915},{"date":"2020-12-04","current":16.468751,"twenty":19.105699,"median":28.124531,"eighty":73.576979,"marketCap":51975378191},{"date":"2020-12-11","current":16.0447,"twenty":19.031974,"median":28.045787,"eighty":73.249222,"marketCap":50637074210},{"date":"2020-12-18","current":16.684121,"twenty":18.978847,"median":28.003825,"eighty":72.725467,"marketCap":52655084629},{"date":"2020-12-24","current":16.351033,"twenty":18.951722,"median":27.893932,"eighty":72.508831,"marketCap":51603861628},{"date":"2020-12-31","current":16.156398,"twenty":18.869944,"median":27.783005,"eighty":72.122981,"marketCap":50989592766},{"date":"2021-01-08","current":16.67877,"twenty":18.812345,"median":27.748475,"eighty":71.867927,"marketCap":52638197512},{"date":"2021-01-15","current":17.320865,"twenty":18.741004,"median":27.670408,"eighty":71.690256,"marketCap":54664651490},{"date":"2021-01-22","current":17.984699,"twenty":18.702345,"median":27.64431,"eighty":71.398793,"marketCap":56759709378},{"date":"2021-01-29","current":16.849661,"twenty":18.613885,"median":27.588588,"eighty":71.196483,"marketCap":53177529795},{"date":"2021-02-05","current":14.990488,"twenty":18.469712,"median":27.52903,"eighty":70.956334,"marketCap":52664583632},{"date":"2021-02-12","current":14.395598,"twenty":18.339492,"median":27.404838,"eighty":70.822506,"marketCap":50574613240},{"date":"2021-02-19","current":13.94353,"twenty":18.247865,"median":27.322464,"eighty":70.650351,"marketCap":48986410835},{"date":"2021-02-26","current":13.356584,"twenty":18.183087,"median":27.239458,"eighty":70.34583,"marketCap":46924351319},{"date":"2021-03-05","current":13.682665,"twenty":18.137069,"median":27.131182,"eighty":70.094632,"marketCap":48069939939},{"date":"2021-03-12","current":13.975842,"twenty":18.094122,"median":27.034693,"eighty":69.991059,"marketCap":49099928253},{"date":"2021-03-19","current":14.042244,"twenty":17.992123,"median":26.957419,"eighty":69.774786,"marketCap":49333211754},{"date":"2021-03-26","current":14.1374,"twenty":17.91755,"median":26.838925,"eighty":69.560413,"marketCap":49667515342},{"date":"2021-04-01","current":14.078706,"twenty":17.836459,"median":26.740955,"eighty":69.380807,"marketCap":49461309390},{"date":"2021-04-09","current":14.08582,"twenty":17.582883,"median":26.667813,"eighty":69.047731,"marketCap":49486304051},{"date":"2021-04-16","current":14.898948,"twenty":17.531653,"median":26.603923,"eighty":68.92796,"marketCap":52342985492},{"date":"2021-04-23","current":14.400461,"twenty":17.378502,"median":26.576788,"eighty":68.754213,"marketCap":50591699595},{"date":"2021-04-30","current":14.184148,"twenty":17.314319,"median":26.47571,"eighty":68.667059,"marketCap":49831747330},{"date":"2021-05-07","current":12.848195,"twenty":17.236982,"median":26.416524,"eighty":68.548435,"marketCap":51441604940},{"date":"2021-05-14","current":13.362123,"twenty":17.131868,"median":26.350888,"eighty":68.476599,"marketCap":53499269138},{"date":"2021-05-21","current":13.106065,"twenty":16.947039,"median":26.270161,"eighty":68.395732,"marketCap":52474061510},{"date":"2021-05-28","current":12.995106,"twenty":16.837354,"median":26.029338,"eighty":68.15674,"marketCap":52029804872},{"date":"2021-06-04","current":13.239784,"twenty":16.702149,"median":25.825146,"eighty":68.017841,"marketCap":53009447716},{"date":"2021-06-11","current":13.593093,"twenty":16.634935,"median":25.762014,"eighty":67.890019,"marketCap":54424027129},{"date":"2021-06-18","current":13.913037,"twenty":16.514074,"median":25.58899,"eighty":67.722101,"marketCap":55705018881},{"date":"2021-06-25","current":14.239706,"twenty":16.438175,"median":25.425582,"eighty":67.525077,"marketCap":57012935279},{"date":"2021-07-02","current":15.095563,"twenty":16.378422,"median":25.38134,"eighty":67.387984,"marketCap":60439614106},{"date":"2021-07-09","current":15.011762,"twenty":16.299089,"median":25.245133,"eighty":67.28571,"marketCap":60104091610},{"date":"2021-07-16","current":15.085217,"twenty":16.168829,"median":25.161304,"eighty":66.948314,"marketCap":60398191576},{"date":"2021-07-23","current":15.165656,"twenty":16.140773,"median":25.057563,"eighty":66.699512,"marketCap":60720251750},{"date":"2021-07-30","current":14.862006,"twenty":16.05773,"median":24.844212,"eighty":66.473671,"marketCap":59504500482},{"date":"2021-08-06","current":10.234607,"twenty":15.941934,"median":24.580228,"eighty":66.222266,"marketCap":63509831394},{"date":"2021-08-13","current":10.467996,"twenty":15.811105,"median":24.409963,"eighty":65.572203,"marketCap":64958104241},{"date":"2021-08-20","current":11.112707,"twenty":15.71172,"median":24.133895,"eighty":65.35903,"marketCap":68958789033},{"date":"2021-08-27","current":11.113042,"twenty":15.594292,"median":23.952572,"eighty":64.943681,"marketCap":68960868391},{"date":"2021-09-03","current":11.385804,"twenty":15.416611,"median":23.896291,"eighty":64.163045,"marketCap":70653465803},{"date":"2021-09-10","current":10.898585,"twenty":15.358543,"median":23.822687,"eighty":64.001642,"marketCap":67630079271},{"date":"2021-09-17","current":10.921874,"twenty":15.31188,"median":23.556993,"eighty":63.614678,"marketCap":67774594652},{"date":"2021-09-24","current":10.704401,"twenty":15.216063,"median":23.36376,"eighty":63.039237,"marketCap":66425091310},{"date":"2021-10-01","current":9.563257,"twenty":15.168295,"median":23.248274,"eighty":62.60394,"marketCap":59343837641},{"date":"2021-10-08","current":9.215268,"twenty":15.152615,"median":23.044477,"eighty":62.187301,"marketCap":57184424358},{"date":"2021-10-15","current":9.269217,"twenty":15.096804,"median":22.886718,"eighty":61.909902,"marketCap":57519200996},{"date":"2021-10-22","current":9.589562,"twenty":15.075632,"median":22.781044,"eighty":60.689685,"marketCap":59507067244},{"date":"2021-10-29","current":10.721826,"twenty":15.02843,"median":22.711601,"eighty":58.441572,"marketCap":66533217926},{"date":"2021-11-05","current":9.140146,"twenty":15.010362,"median":22.587367,"eighty":56.983625,"marketCap":63939894320},{"date":"2021-11-12","current":9.433987,"twenty":14.972274,"median":22.403299,"eighty":52.676989,"marketCap":65995456216},{"date":"2021-11-19","current":9.75503,"twenty":14.914028,"median":22.242861,"eighty":51.731325,"marketCap":68241309194},{"date":"2021-11-26","current":9.615582,"twenty":14.873644,"median":22.206358,"eighty":51.46717,"marketCap":67265806015},{"date":"2021-12-03","current":9.493174,"twenty":14.846146,"median":22.027357,"eighty":51.289641,"marketCap":66409496151},{"date":"2021-12-10","current":10.006722,"twenty":14.763396,"median":21.89368,"eighty":50.996878,"marketCap":70002024471},{"date":"2021-12-17","current":9.255829,"twenty":14.645835,"median":21.852902,"eighty":50.192382,"marketCap":64749154191},{"date":"2021-12-23","current":9.347001,"twenty":14.543935,"median":21.806579,"eighty":49.835452,"marketCap":65386942979},{"date":"2021-12-31","current":9.43877,"twenty":14.480705,"median":21.69052,"eighty":32.798336,"marketCap":66028913989},{"date":"2022-01-07","current":9.023417,"twenty":14.400343,"median":21.58144,"eighty":31.955254,"marketCap":63123315560},{"date":"2022-01-14","current":9.195447,"twenty":14.360499,"median":21.468059,"eighty":31.332217,"marketCap":64326749814},{"date":"2022-01-21","current":9.287515,"twenty":14.29746,"median":21.412668,"eighty":31.053495,"marketCap":64970811934},{"date":"2022-01-28","current":9.340125,"twenty":14.271924,"median":21.249665,"eighty":30.821672,"marketCap":65338847431},{"date":"2022-02-04","current":8.06582,"twenty":14.211698,"median":21.155814,"eighty":30.665092,"marketCap":65133918575},{"date":"2022-02-11","current":8.414784,"twenty":14.141195,"median":20.886786,"eighty":30.397746,"marketCap":67951902021},{"date":"2022-02-18","current":8.107934,"twenty":14.100469,"median":20.718789,"eighty":30.063963,"marketCap":65473995536},{"date":"2022-02-25","current":8.154462,"twenty":14.0749,"median":20.630748,"eighty":29.944922,"marketCap":65849726202},{"date":"2022-03-04","current":8.177528,"twenty":14.052898,"median":20.548589,"eighty":29.711783,"marketCap":66035994945},{"date":"2022-03-11","current":8.469748,"twenty":13.990355,"median":20.497058,"eighty":29.510771,"marketCap":68395753827},{"date":"2022-03-18","current":9.041269,"twenty":13.952186,"median":20.431603,"eighty":29.231348,"marketCap":73010961095},{"date":"2022-03-25","current":8.96337,"twenty":13.923409,"median":20.297711,"eighty":29.102336,"marketCap":72381904938},{"date":"2022-04-01","current":9.158447,"twenty":13.87369,"median":20.180575,"eighty":28.966736,"marketCap":73957206312},{"date":"2022-04-08","current":9.738536,"twenty":13.848877,"median":20.056598,"eighty":28.871934,"marketCap":78641599112},{"date":"2022-04-14","current":9.661823,"twenty":13.817339,"median":19.925312,"eighty":28.815517,"marketCap":78022122491},{"date":"2022-04-22","current":9.180836,"twenty":13.785109,"median":19.790673,"eighty":28.696957,"marketCap":74138001167},{"date":"2022-04-29","current":8.794298,"twenty":13.737566,"median":19.660289,"eighty":28.556678,"marketCap":71016593927},{"date":"2022-05-06","current":8.46164,"twenty":13.72215,"median":19.591904,"eighty":28.472288,"marketCap":67131266171},{"date":"2022-05-13","current":8.766805,"twenty":13.695689,"median":19.451906,"eighty":28.362701,"marketCap":69552323150},{"date":"2022-05-20","current":8.97894,"twenty":13.651777,"median":19.315239,"eighty":28.201625,"marketCap":71235318701},{"date":"2022-05-27","current":9.408914,"twenty":13.61647,"median":19.182482,"eighty":28.169777,"marketCap":74646563203},{"date":"2022-06-03","current":8.560781,"twenty":13.580763,"median":19.147609,"eighty":28.138912,"marketCap":67917813387},{"date":"2022-06-10","current":7.76575,"twenty":13.496152,"median":19.040029,"eighty":28.05351,"marketCap":61610351191},{"date":"2022-06-17","current":7.88988,"twenty":13.458929,"median":18.983291,"eighty":28.012848,"marketCap":62595151404},{"date":"2022-06-24","current":8.318225,"twenty":13.394252,"median":18.968689,"eighty":27.917096,"marketCap":65993466363},{"date":"2022-07-01","current":8.086125,"twenty":13.329334,"median":18.871653,"eighty":27.782289,"marketCap":64152083907},{"date":"2022-07-08","current":8.44154,"twenty":13.241565,"median":18.818752,"eighty":27.753004,"marketCap":66971801804},{"date":"2022-07-15","current":8.250999,"twenty":13.112583,"median":18.780003,"eighty":27.691117,"marketCap":65460122702},{"date":"2022-07-22","current":7.959958,"twenty":13.007521,"median":18.702505,"eighty":27.643858,"marketCap":63151121765},{"date":"2022-07-29","current":7.89993,"twenty":12.891389,"median":18.620106,"eighty":27.587706,"marketCap":62674883587},{"date":"2022-08-05","current":11.535488,"twenty":11.550716,"median":18.471047,"eighty":27.528467,"marketCap":65600015462},{"date":"2022-08-12","current":11.819359,"twenty":11.550716,"median":18.341073,"eighty":27.404209,"marketCap":67214331124},{"date":"2022-08-19","current":11.624785,"twenty":11.550716,"median":18.231129,"eighty":27.303428,"marketCap":66107829991},{"date":"2022-08-26","current":11.207815,"twenty":11.371909,"median":18.181433,"eighty":27.225906,"marketCap":63736603409},{"date":"2022-09-02","current":10.915297,"twenty":11.30967,"median":18.134856,"eighty":27.121826,"marketCap":62073109919},{"date":"2022-09-09","current":13.616768,"twenty":11.259308,"median":18.095368,"eighty":27.037827,"marketCap":77435835791},{"date":"2022-09-16","current":13.353201,"twenty":11.259308,"median":17.997073,"eighty":26.966349,"marketCap":75936981116},{"date":"2022-09-23","current":13.109373,"twenty":11.259308,"median":17.919992,"eighty":26.835951,"marketCap":74550380180},{"date":"2022-09-30","current":12.95033,"twenty":11.259308,"median":17.763862,"eighty":26.722775,"marketCap":73645935776},{"date":"2022-10-07","current":13.580109,"twenty":11.259308,"median":17.582147,"eighty":26.649626,"marketCap":77227364563},{"date":"2022-10-14","current":13.837473,"twenty":11.259308,"median":17.514489,"eighty":26.601993,"marketCap":78690939491},{"date":"2022-10-21","current":13.421066,"twenty":11.259308,"median":17.357987,"eighty":26.567778,"marketCap":76322920159},{"date":"2022-10-28","current":14.113824,"twenty":11.259308,"median":17.305502,"eighty":26.472046,"marketCap":80262491824},{"date":"2022-11-04","current":14.720939,"twenty":11.259308,"median":17.230044,"eighty":26.401701,"marketCap":79055860306},{"date":"2022-11-11","current":14.606387,"twenty":11.259308,"median":17.119207,"eighty":26.346411,"marketCap":78440681160},{"date":"2022-11-18","current":14.651731,"twenty":11.259308,"median":16.930926,"eighty":26.239227,"marketCap":78684189572},{"date":"2022-11-25","current":14.641787,"twenty":11.259308,"median":16.849661,"eighty":26.033735,"marketCap":78630788605},{"date":"2022-12-02","current":15.241595,"twenty":11.259308,"median":16.684121,"eighty":25.823128,"marketCap":81851934964},{"date":"2022-12-09","current":14.916831,"twenty":11.259308,"median":16.625596,"eighty":25.738839,"marketCap":80107859366},{"date":"2022-12-16","current":14.382056,"twenty":11.259308,"median":16.468751,"eighty":25.567197,"marketCap":77235955333},{"date":"2022-12-23","current":14.453054,"twenty":11.259308,"median":16.426279,"eighty":25.414911,"marketCap":77617238241},{"date":"2022-12-30","current":14.348645,"twenty":11.259308,"median":16.386349,"eighty":25.384384,"marketCap":77056528083},{"date":"2023-01-06","current":14.660083,"twenty":11.259308,"median":16.317075,"eighty":25.250581,"marketCap":78729046385},{"date":"2023-01-13","current":14.361373,"twenty":11.259308,"median":16.169536,"eighty":25.174538,"marketCap":77124881321},{"date":"2023-01-20","current":14.358788,"twenty":11.259308,"median":16.151382,"eighty":25.098264,"marketCap":77110997070},{"date":"2023-01-27","current":14.773045,"twenty":11.259308,"median":16.092523,"eighty":24.875579,"marketCap":79335681376},{"date":"2023-02-03","current":19.278951,"twenty":11.259308,"median":15.99554,"eighty":24.688912,"marketCap":83639799356},{"date":"2023-02-10","current":18.637362,"twenty":11.259308,"median":15.99554,"eighty":24.479131,"marketCap":80856330298},{"date":"2023-02-17","current":18.419158,"twenty":11.259308,"median":15.99554,"eighty":24.334872,"marketCap":79909674829},{"date":"2023-02-24","current":18.62211,"twenty":11.259308,"median":15.99554,"eighty":24.08253,"marketCap":80790160468},{"date":"2023-03-03","current":19.17094,"twenty":11.259308,"median":15.99554,"eighty":23.912342,"marketCap":83171207087},{"date":"2023-03-10","current":18.376354,"twenty":11.259308,"median":15.99554,"eighty":23.83133,"marketCap":79723972404},{"date":"2023-03-17","current":18.392344,"twenty":11.259308,"median":15.99554,"eighty":23.634714,"marketCap":79793343999},{"date":"2023-03-24","current":20.172169,"twenty":11.259308,"median":15.99554,"eighty":23.395584,"marketCap":87514936240},{"date":"2023-03-31","current":20.213251,"twenty":11.270868,"median":16.006911,"eighty":23.269698,"marketCap":87693167878},{"date":"2023-04-06","current":20.300582,"twenty":11.270868,"median":16.006911,"eighty":23.16464,"marketCap":88072043517},{"date":"2023-04-14","current":20.426781,"twenty":11.259308,"median":15.99554,"eighty":22.981137,"marketCap":88619545496},{"date":"2023-04-21","current":19.633424,"twenty":11.259308,"median":15.99554,"eighty":22.826311,"marketCap":85177647089},{"date":"2023-04-28","current":19.560756,"twenty":11.259308,"median":15.99554,"eighty":22.744778,"marketCap":84862383141},{"date":"2023-05-05","current":19.3053,"twenty":11.259308,"median":15.99554,"eighty":22.693077,"marketCap":80748278285},{"date":"2023-05-12","current":19.092498,"twenty":11.247747,"median":15.988674,"eighty":22.679792,"marketCap":79858192074},{"date":"2023-05-19","current":19.141409,"twenty":11.247747,"median":15.988674,"eighty":22.52179,"marketCap":80062772659},{"date":"2023-05-26","current":18.565743,"twenty":11.247747,"median":15.988674,"eighty":22.52179,"marketCap":77654934150},{"date":"2023-06-02","current":18.723744,"twenty":11.247747,"median":15.988674,"eighty":22.416292,"marketCap":78315804417},{"date":"2023-06-09","current":19.209014,"twenty":11.247747,"median":15.988674,"eighty":22.202364,"marketCap":80345543730},{"date":"2023-06-16","current":20.052795,"twenty":11.247747,"median":15.988674,"eighty":21.930123,"marketCap":83874826599},{"date":"2023-06-23","current":19.969313,"twenty":11.236187,"median":15.981807,"eighty":21.872257,"marketCap":83525647171},{"date":"2023-06-30","current":18.141164,"twenty":11.224626,"median":15.96462,"eighty":21.812599,"marketCap":75879046138},{"date":"2023-07-07","current":18.049231,"twenty":11.224626,"median":15.96462,"eighty":21.69052,"marketCap":75494520326},{"date":"2023-07-14","current":18.462799,"twenty":11.224626,"median":15.96462,"eighty":21.546615,"marketCap":77224350928},{"date":"2023-07-21","current":18.51504,"twenty":11.224626,"median":15.96462,"eighty":21.443977,"marketCap":77442855847},{"date":"2023-07-28","current":19.069195,"twenty":11.224626,"median":15.96462,"eighty":21.26942,"marketCap":79760721743},{"date":"2023-08-04","current":19.014155,"twenty":11.224626,"median":15.96462,"eighty":21.191438,"marketCap":81741853001},{"date":"2023-08-11","current":19.545551,"twenty":11.224626,"median":15.96462,"eighty":20.904333,"marketCap":84026322961},{"date":"2023-08-18","current":19.637239,"twenty":11.224626,"median":15.96462,"eighty":20.742089,"marketCap":84420489392},{"date":"2023-08-25","current":20.487077,"twenty":11.224626,"median":15.96462,"eighty":20.708932,"marketCap":88073945988},{"date":"2023-09-01","current":20.370742,"twenty":11.224626,"median":15.96462,"eighty":20.579258,"marketCap":87573820839},{"date":"2023-09-08","current":20.340426,"twenty":11.224626,"median":15.96462,"eighty":20.556869,"marketCap":87443491616},{"date":"2023-09-15","current":20.515915,"twenty":11.224626,"median":15.96462,"eighty":20.525527,"marketCap":88197917688},{"date":"2023-09-22","current":20.294089,"twenty":11.224626,"median":15.96462,"eighty":20.503675,"marketCap":87244289226},{"date":"2023-09-29","current":20.569892,"twenty":11.224626,"median":15.96462,"eighty":20.497429,"marketCap":88429967281},{"date":"2023-10-06","current":20.484859,"twenty":11.224626,"median":15.96462,"eighty":20.47919,"marketCap":88064409704},{"date":"2023-10-13","current":20.66651,"twenty":11.224626,"median":15.96462,"eighty":20.47919,"marketCap":88845325455},{"date":"2023-10-20","current":19.930788,"twenty":11.224626,"median":15.96462,"eighty":20.469796,"marketCap":85682457723},{"date":"2023-10-27","current":19.520904,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":83920364243},{"date":"2023-11-03","current":21.737851,"twenty":11.217472,"median":15.933685,"eighty":20.408361,"marketCap":86757938711},{"date":"2023-11-10","current":21.323755,"twenty":11.217472,"median":15.933685,"eighty":20.408361,"marketCap":85105237415},{"date":"2023-11-17","current":21.224631,"twenty":11.217472,"median":15.933685,"eighty":20.421192,"marketCap":84709626635},{"date":"2023-11-24","current":21.271528,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":84896797327},{"date":"2023-12-01","current":21.951269,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":87609708889},{"date":"2023-12-08","current":22.627279,"twenty":11.219857,"median":15.940559,"eighty":20.455788,"marketCap":90307731873},{"date":"2023-12-15","current":23.341925,"twenty":11.219857,"median":15.940559,"eighty":20.455788,"marketCap":93159957984},{"date":"2023-12-22","current":22.432763,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":89531398889},{"date":"2023-12-29","current":23.493808,"twenty":11.215088,"median":15.919407,"eighty":20.445674,"marketCap":93766135792},{"date":"2024-01-05","current":24.305712,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":97006528395},{"date":"2024-01-12","current":24.406967,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":97410646934},{"date":"2024-01-19","current":24.780811,"twenty":11.212541,"median":15.891644,"eighty":20.415603,"marketCap":98902695120},{"date":"2024-01-26","current":25.283622,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":100909462708},{"date":"2024-02-02","current":25.521038,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":101857014335},{"date":"2024-02-09","current":25.724697,"twenty":11.212703,"median":15.905129,"eighty":20.459114,"marketCap":101705162231},{"date":"2024-02-16","current":25.950297,"twenty":11.212703,"median":15.905129,"eighty":20.47919,"marketCap":102597095968},{"date":"2024-02-23","current":26.226454,"twenty":11.212703,"median":15.905129,"eighty":20.497429,"marketCap":103688908831},{"date":"2024-03-01","current":26.259071,"twenty":11.215088,"median":15.919407,"eighty":20.518368,"marketCap":103817863106},{"date":"2024-03-08","current":26.455316,"twenty":11.215088,"median":15.919407,"eighty":20.545637,"marketCap":104593737995},{"date":"2024-03-15","current":26.067447,"twenty":11.215088,"median":15.919407,"eighty":20.571273,"marketCap":103060256739},{"date":"2024-03-22","current":26.311258,"twenty":11.215088,"median":15.919407,"eighty":20.621194,"marketCap":104024189946},{"date":"2024-03-28","current":26.264779,"twenty":11.215088,"median":15.919407,"eighty":20.655603,"marketCap":103840430104},{"date":"2024-04-05","current":25.468926,"twenty":11.212703,"median":15.905129,"eighty":20.723691,"marketCap":100693945789},{"date":"2024-04-12","current":25.015007,"twenty":11.212703,"median":15.905129,"eighty":20.904157,"marketCap":98899332126},{"date":"2024-04-19","current":24.299337,"twenty":11.212703,"median":15.947434,"eighty":21.122307,"marketCap":96069860405},{"date":"2024-04-26","current":24.304801,"twenty":11.215088,"median":16.055559,"eighty":21.212036,"marketCap":96091459812},{"date":"2024-05-03","current":26.22078,"twenty":11.215088,"median":16.138956,"eighty":21.263447,"marketCap":101154526467},{"date":"2024-05-10","current":27.070653,"twenty":11.215088,"median":16.168653,"eighty":21.31672,"marketCap":104433166904},{"date":"2024-05-17","current":27.070094,"twenty":11.215088,"median":16.294592,"eighty":21.377367,"marketCap":104431009193},{"date":"2024-05-24","current":27.42218,"twenty":11.215088,"median":16.403186,"eighty":21.543145,"marketCap":105789287676},{"date":"2024-05-31","current":27.124068,"twenty":11.215088,"median":16.446392,"eighty":21.604318,"marketCap":104639228214},{"date":"2024-06-07","current":27.987644,"twenty":11.215088,"median":16.556015,"eighty":21.765364,"marketCap":107970732547},{"date":"2024-06-14","current":28.708036,"twenty":11.212703,"median":16.641161,"eighty":21.875339,"marketCap":110749863104},{"date":"2024-06-21","current":29.206942,"twenty":11.212541,"median":16.702347,"eighty":21.926914,"marketCap":112674540478},{"date":"2024-06-28","current":29.387879,"twenty":11.212055,"median":16.849661,"eighty":22.012139,"marketCap":113372559682},{"date":"2024-07-05","current":28.639241,"twenty":11.212055,"median":16.930926,"eighty":22.201171,"marketCap":110484464767},{"date":"2024-07-12","current":30.210346,"twenty":11.212055,"median":17.140309,"eighty":22.42349,"marketCap":116545472325},{"date":"2024-07-15","current":30.763504,"twenty":11.212055,"median":17.191109,"eighty":22.533173,"marketCap":118679447575},{"date":"2024-08-02","current":27.30119,"twenty":11.206899,"median":17.301169,"eighty":22.615128,"marketCap":117987551031},{"date":"2024-08-09","current":27.805935,"twenty":11.206899,"median":17.352971,"eighty":22.804619,"marketCap":120168907862},{"date":"2024-08-16","current":29.353886,"twenty":11.206899,"median":17.547174,"eighty":23.185349,"marketCap":126858689969},{"date":"2024-08-23","current":29.661828,"twenty":11.206899,"median":17.668241,"eighty":23.520288,"marketCap":128189522712},{"date":"2024-08-30","current":29.443796,"twenty":11.206899,"median":17.89624,"eighty":23.992786,"marketCap":127247254273},{"date":"2024-09-06","current":28.735255,"twenty":11.206899,"median":18.004331,"eighty":24.127024,"marketCap":124185151686},{"date":"2024-09-13","current":29.082408,"twenty":11.206899,"median":18.146003,"eighty":24.305165,"marketCap":125685441639},{"date":"2024-09-20","current":28.726014,"twenty":11.206899,"median":18.30367,"eighty":24.388542,"marketCap":124145215910},{"date":"2024-09-27","current":25.973018,"twenty":11.206899,"median":18.360535,"eighty":24.456418,"marketCap":112247592778},{"date":"2024-10-04","current":25.339402,"twenty":11.206899,"median":18.388792,"eighty":24.700046,"marketCap":109509293778},{"date":"2024-10-11","current":24.950541,"twenty":11.206899,"median":18.407637,"eighty":24.906035,"marketCap":107828753161},{"date":"2024-10-18","current":24.930811,"twenty":11.206899,"median":18.470866,"eighty":25.028446,"marketCap":107743484883},{"date":"2024-10-25","current":23.199293,"twenty":11.206899,"median":18.52949,"eighty":25.028446,"marketCap":100260383988},{"date":"2024-10-31","current":23.046696,"twenty":11.206899,"median":18.566384,"eighty":25.028446,"marketCap":99600904015},{"date":"2024-11-08","current":19.05799,"twenty":11.206442,"median":18.637362,"eighty":25.035165,"marketCap":88705416518},{"date":"2024-11-15","current":18.087847,"twenty":11.206442,"median":18.657932,"eighty":25.035165,"marketCap":84189883902},{"date":"2024-11-22","current":17.20924,"twenty":11.206442,"median":18.657932,"eighty":25.035165,"marketCap":80100405829},{"date":"2024-11-29","current":17.341458,"twenty":11.206442,"median":18.64179,"eighty":25.035165,"marketCap":80715817946},{"date":"2024-12-06","current":17.750134,"twenty":11.206442,"median":18.605435,"eighty":25.035165,"marketCap":82618000854},{"date":"2024-12-13","current":17.127643,"twenty":11.206442,"median":18.54394,"eighty":25.035165,"marketCap":79720614785},{"date":"2024-12-20","current":16.371315,"twenty":11.206442,"median":18.478932,"eighty":25.035165,"marketCap":76200285330},{"date":"2024-12-27","current":16.566176,"twenty":11.206442,"median":18.419158,"eighty":25.035165,"marketCap":77107265077},{"date":"2025-01-03","current":16.531734,"twenty":11.206442,"median":18.397243,"eighty":25.035165,"marketCap":76946956675},{"date":"2025-01-10","current":16.957053,"twenty":11.205984,"median":18.379244,"eighty":25.041885,"marketCap":78926604046},{"date":"2025-01-17","current":16.024125,"twenty":11.205984,"median":18.326784,"eighty":25.041885,"marketCap":74584290575},{"date":"2025-01-24","current":16.056718,"twenty":11.205984,"median":18.268644,"eighty":25.041885,"marketCap":74735991813},{"date":"2025-01-31","current":15.789506,"twenty":11.205984,"median":18.268644,"eighty":25.041885,"marketCap":73492256835},{"date":"2025-02-07","current":17.513328,"twenty":11.205984,"median":18.205402,"eighty":25.041885,"marketCap":77279312131},{"date":"2025-02-14","current":16.353971,"twenty":11.205984,"median":18.068539,"eighty":25.041885,"marketCap":72163532332},{"date":"2025-02-21","current":16.881503,"twenty":11.205984,"median":17.989927,"eighty":25.041885,"marketCap":74491319165},{"date":"2025-02-28","current":17.045462,"twenty":11.205984,"median":17.861315,"eighty":25.041885,"marketCap":75214806015},{"date":"2025-03-07","current":16.940198,"twenty":11.205526,"median":17.547284,"eighty":24.953276,"marketCap":74750318896},{"date":"2025-03-14","current":16.507743,"twenty":11.205526,"median":17.434844,"eighty":24.953276,"marketCap":72842068816},{"date":"2025-03-21","current":16.071408,"twenty":11.205526,"median":17.347954,"eighty":24.876365,"marketCap":70916694786},{"date":"2025-03-28","current":15.421634,"twenty":11.205526,"median":17.320865,"eighty":24.876365,"marketCap":68049503556},{"date":"2025-04-04","current":14.810668,"twenty":11.205526,"median":17.220578,"eighty":24.757629,"marketCap":65353551816},{"date":"2025-04-11","current":13.252327,"twenty":11.205984,"median":17.191443,"eighty":24.571362,"marketCap":58477215997},{"date":"2025-04-17","current":13.322422,"twenty":11.205984,"median":17.137002,"eighty":24.420237,"marketCap":58786517328},{"date":"2025-04-25","current":14.54678,"twenty":11.205526,"median":16.999149,"eighty":24.304801,"marketCap":64189123276},{"date":"2025-05-02","current":13.856076,"twenty":11.205526,"median":16.947475,"eighty":24.14557,"marketCap":62342643230},{"date":"2025-05-09","current":12.861961,"twenty":11.205526,"median":16.904119,"eighty":24.034457,"marketCap":57869822741}],"updateTime":1746934174055}}}